Investigational Site Number :8040011

Kharkiv 61166

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Heart Failure, Non-relapsing Secondary Progressive Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed
• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early
• Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants — Completed